Mystic Pharmaceuticals has received notices of allowance from the China Patent Office and the Japan Patent Office for its 'Deep Draw Container Forming Method' and 'Combination Unit Dose Dispensing Container' patent applications ...
Tags: Drug Delivery Platforms, Medicine
US-based Mystic Pharmaceuticals has secured two Notices of Allowance from the US Patent Office for its Unit Dose Drug Delivery Platform and Piercing Device for Drug Delivery Systems patent applications. According to the company, the new ...
First Solar Inc of Tempe, AZ, USA, which makes thin-film photovoltaic modules based on cadmium telluride (CdTe) as well as providing engineering, procurement & construction (EPC) services, and BELECTRIC Holding GmbH are to undertake a joint ...
Tags: PV Projects, Solar
RNAi therapeutics company Alnylam Pharmaceuticals has obtained additional orphan drug designation from US FDA for a RNAi therapeutic, ALN-AT3, to treat hemophilia A. With the additional approval, orphan drug designation for GalNAc ...
Tags: Alnylam, Orphan Drug
Clinical stage biopharma company Rexahn Pharmaceuticals has entered into an exclusive licensing agreement with the University of Maryland, Baltimore (UMB), for a novel drug delivery platform, which targets the delivery of chemotherapeutic ...
Tags: Rexahn Pharma, Oncology Drug
Mobile Helix, the enterprise application and data security platform provider, has launched Link, which it describes as the industry’s first pure HTML5 platform. Link unlocks enterprise productivity by combining unparalleled security ...
Tags: Mobile Helix, Link, HTML5 Platform
With Yahoo CEO Marissa Mayer taking steps to transform the company back into a top-tier player, reports are out that Yahoo is in talks to buy Hulu for as much as $800 million. Yahoo bid between $600 million and $800 million for Hulu, a ...
Tags: Yahoo, Mobile User
Experience Media Studios today announced the worldwide launch of its patent-pending 3DPOV? system, a pioneering new solution for capturing, delivering, and experiencing immersive media. Experience Media Studios' 3DPOV system enables the ...
Tags: Media Capture, Delivery System
Israel-based innovative drug carriers developer PolyPid has signed a strategic partnership agreement with MIS Implants Technologies, a US- based dental implants manufacturer, to provide a new drug delivery product for dental applications. ...
Tags: MIS, drug delivery product, innovative drug
Rainbow BioSciences' biotech division Rainbow Coral (RBCC) has revealed that it is currently working on a potential joint venture agreement with a privately held drug delivery company to develop and market a sustained-release drug delivery ...
Tags: RBCC, Sustained-Release Drug, Medicine
TissueGen® Inc., developer of a cutting-edge absorbable polymer technology for implantable drug delivery across a wide variety of therapeutic applications, today announced that its patented extrusion technology enables absorbable fibers ...
Tags: cutting-edge absorbable polymer technology, implantable drug delivery
ScinoPharm and Foresee Pharmaceuticals have signed an agreement to form a joint venture for developing a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug used for treating prostate cancer. ...
NanoSmart Pharmaceuticals and University of California Los Angeles (UCLA) have signed a research alliance to advance the development of the drug delivery platform that uses human autoimmune antibodies targeting several tumor types. ...
IDG News Service - As TVs get higher resolution and bigger displays, while getting cheaper over time, cable operators may be able to cover an entire wall of your home with a screen that includes two full-size TV shows plus weather, upcoming ...
Tags: cable operators, TV, Cisco Systems, tablets, computer
Halozyme Therapeutics has entered into collaboration and license agreement with Pfizer for the development and commercialization of subcutaneous biologics. The collaboration will focus on developing Pfizer biologics, leveraging Halozyme's ...
Tags: biologics, Halozyme Therapeutics, subcutaneous biologics, treatments